ASX:EMV EMVision Medical Devices (EMV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About EMVision Medical Devices Stock (ASX:EMV) 30 days 90 days 365 days Advanced Chart Get EMV alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume192,157 shsAverage VolumeN/AMarket CapitalizationA$165.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview EMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia. Read More Receive EMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMVision Medical Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address EMV Stock News HeadlinesEMVision makes progress in key trials for bedside brain scannerJuly 1, 2025 | msn.comEMVision Secures $5M Grant to Advance Brain Scanner CommercializationJune 15, 2025 | tipranks.comThis Cold War “Accident” Could Unleash New $100 Trillion AI BoomObscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.July 8 at 2:00 AM | Brownstone Research (Ad)ASX Penny Stocks: EMVision Medical Devices Leads Our Trio Of PicksJune 13, 2025 | finance.yahoo.comScott Power: ASX health stocks dip but it was a good news week for EMVisionJune 6, 2025 | msn.comStockTake: EMVision expands trial for bedside stroke scannerJune 3, 2025 | msn.comEMVision advances its AI-driven stroke diagnosticsMay 21, 2025 | msn.comASX medtechs transforming brain diagnostics for better outcomesMay 9, 2025 | msn.comSee More Headlines EMV Stock Analysis - Frequently Asked Questions How were EMVision Medical Devices' earnings last quarter? EMVision Medical Devices Ltd (ASX:EMV) announced its earnings results on Tuesday, February, 26th. The company reported ($4.47) EPS for the quarter. EMVision Medical Devices had a negative trailing twelve-month return on equity of 22.53% and a negative net margin of 24.33%. Company Calendar Last Earnings2/26/2019Today7/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:EMV CIKN/A Webwww.emvision.com.au Phone61 2 8667 5337FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$2.73 million Net Margins-24.33% Pretax MarginN/A Return on Equity-22.53% Return on Assets-7.95% Debt Debt-to-Equity Ratio15.66 Current Ratio6.40 Quick Ratio8.04 Sales & Book Value Annual SalesA$11.22 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.47 Book ValueA$0.22 per share Price / BookN/AMiscellaneous Outstanding Shares85,520,000Free FloatN/AMarket CapA$165.05 million OptionableNot Optionable Beta1.47 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (ASX:EMV) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThirty-Year “Wonder Material” Finally Ready for Factory FloorsA Nobel-recognized material once trapped in research labs is finally ready for the real world. After a 90% ...True Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMVision Medical Devices Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share EMVision Medical Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.